Rotavirus Vaccine
Bovine-human rotavirus reassortant tetravalent vaccine safe and immunogenetic
Published in Vaccine Weekly, October 4th, 2006
"Live oral rhesus-rhesus-human rotavirus reassortant tetravalent (RRV-TV) vaccine was efficacious against rotavirus gastroenteritis but was withdrawn because of a rare association with intussusception.
"A corresponding tetravalent (types G1, G2, G3, and G4) reassortant vaccine based on bovine-human (UK) rotavirus reassortant tetravalent (BRV-TV) vaccine was developed concurrently," scientists in Finland report.
According to researchers, "Before the withdrawal of RRV-TV vaccine, parallel placebo-controlled trials of BRV-TV vaccine...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2006-10-04)
More Articles from Vaccine Weekly
- Meningitis Vaccine
Haemophilus influenzae type b experience in Alaska is reported - SARS Vaccine
Long-lived memory T cell responses to SARS antigen in recovered SARS patients are described - Vaccine Development
Cell-surface display technology in yeast prepares the source of an oral vaccine - Apoptosis
Neurotrophic factors protect TNF-related apoptosis-inducing ligand-mediated apoptosis - Avian Influenza
BioDiem and Nobilon join top U.S. science facility in race to develop bird flu vaccine - Avian Influenza
Live H5N1 bird flu virus vaccines show protection in animal studies - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
